Global Custom Market Research Reports Provider Company

phone

Nuo Therapeutics Inc (AURX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • Published Date: 09 Nov 2018
  • Number of Pages: 29
  • Category: Company Profile
  • Country: United States of America
Summary

Nuo Therapeutics Inc (Nuo Therapeutics), formerly Cytomedix, is a biomedical company that specializes in biodynamic therapies in the area of wound care. It focuses on commercializing cell-based technologies, which bind the regenerative capacity of the human body to trigger natural healing. The companys flagship product, Aurix System, is a biodynamic hematogel designed to harness a patients innate regenerative abilities to manage a wide range of wounds. Aurix is US FDA approved platelet and plasma therapy system for managing a wide range of ulcers and exuding wounds, including leg ulcer, diabetic ulcer, pressure ulcer, and all severities such as full thickness, partial thickness and complex wounds. The company has its facilities in Nashville, Tennessee; and Durham, North Carolina. Nuo Therapeutics is headquartered in Gaithersburg, Maryland, the US.

Nuo Therapeutics Inc (AURX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons To Buy


Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Publisher Name : GlobalData


List of Tables 4
List of Figures 4
Nuo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Nuo Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Nuo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Nuo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Nuo Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 9
Nuo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Nuo Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Aldagen Raises Additional US$0.06 Million In Venture Financing 11
Equity Offering 12
Nuo Therapeutics to Raise up to USD11.6 Million in Public Offering of Shares 12
Nuo Therapeutics Raises USD7.5 Million in First Tranche of Private Placement 13
Nuo Therapeutics Raises USD7.3 million in Public Offering of Shares 14
Nuo Therapeutics Raises USD2 Million in Private Placement of Shares 15
Cytomedix Completes Private Placement Of Shares For US$5 Million 16
Nuo Therapeutics Raises USD5 Million n Private Placement of Shares and Warrants 17
Cytomedix Announces Private Placement Of Shares For US$15 Million 18
Cytomedix Completes Private Placement Of Shares For US$7 Million 19
Cytomedix Files Registration Statement For Public Offering Of Securities For Up To US$35 Million 20
Debt Offering 21
Cytomedix Raises USD26 Million in Second Tranche of Private Placement Debt Securities Due 2019 21
Cytomedix Completes Private Placement Of Notes For US$3 Million 22
Acquisition 23
Cytomedix Acquires Developer Of Regenerative Cell Therapies, Aldagen 23
Nuo Therapeutics Inc - Key Competitors 25
Nuo Therapeutics Inc - Key Employees 26
Nuo Therapeutics Inc - Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Recent Developments 28
Legal and Regulatory 28
Jul 05, 2017: Nuo Therapeutics Receives Advisory Opinion Waiver for Medicare Part B Co-Payments for Patients in Aurix CED Clinical Studies 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List Of Tables


Nuo Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Nuo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Nuo Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Nuo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Nuo Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Nuo Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 9
Nuo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Aldagen Raises Additional US$0.06 Million In Venture Financing 11
Nuo Therapeutics to Raise up to USD11.6 Million in Public Offering of Shares 12
Nuo Therapeutics Raises USD7.5 Million in First Tranche of Private Placement 13
Nuo Therapeutics Raises USD7.3 million in Public Offering of Shares 14
Nuo Therapeutics Raises USD2 Million in Private Placement of Shares 15
Cytomedix Completes Private Placement Of Shares For US$5 Million 16
Nuo Therapeutics Raises USD5 Million n Private Placement of Shares and Warrants 17
Cytomedix Announces Private Placement Of Shares For US$15 Million 18
Cytomedix Completes Private Placement Of Shares For US$7 Million 19
Cytomedix Files Registration Statement For Public Offering Of Securities For Up To US$35 Million 20
Cytomedix Raises USD26 Million in Second Tranche of Private Placement Debt Securities Due 2019 21
Cytomedix Completes Private Placement Of Notes For US$3 Million 22
Cytomedix Acquires Developer Of Regenerative Cell Therapies, Aldagen 23
Nuo Therapeutics Inc, Key Competitors 25
Nuo Therapeutics Inc, Key Employees 26
Nuo Therapeutics Inc, Other Locations 27
Nuo Therapeutics Inc, Subsidiaries 27

List Of Figures


Nuo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Nuo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Nuo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Nuo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Nuo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Nuo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Nuo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Nuo Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 9

Siemens AG (Siemens) is a technology company that offers products and solutions for electrification, automation and digitization. The company offers products, services and solutions for power generation, transmission and distribution;

View Report

UDG Healthcare plc (UDG) formerly, United Drug plc is a provider of outsourced commercial solutions to healthcare companies. It offers supply chain, packaging, sales and marketing, medical and regulatory services

View Report

Oxurion NV(Oxurion) formerly known as ThromboGenics NV, is a biotechnology company, which develops and commercializes ophthalmic and cancer medicines. The companys ocriplasmin, a recombinant derivative of the plasmin protein, is

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports